Myra Arnott Merck Group

Myra Arnott has been with Merck since 2000. As the Principal Scientist for Validation Strategy, she provides expert leadership and oversight for assay design and validation. She defines the approach to achieve and maintain assay validation and ensure implementation of robust global processes that enable effective execution of assay development and validation.